Live Quote · OTCCBIAHealthcare · Medical - Pharmaceuticals

Canopus Biopharma, Inc.

$0.00▲ 0.00%(+$0.00)

TickerSpark Score

27/100

▌ Poor

20

Valuation

40

Profitability

20

Growth

25

Health

30

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBIA research report →

52-Week Range100% of range

Low

$0.00

Current

$0.00

High

$0.00

Company Overviewwww.blueheaven.cafe

About the company

Canopus Biopharma, Inc. engages in the acquisition of businesses. The company was founded on April 8, 1986 and is headquartered in Las Vegas, NV.

CEO: Justin de Four
IPO: 1999
Employees: 72
HQ: Las Vegas, NV, US

Price Chart

+9900.00% · this period

Valuation

Market Cap: $455.07K
P/E: -0.01
P/S: 0.00
P/B: -0.83
EV/EBITDA: -0.60
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: 12351.93%
ROIC: 25400.66%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-764,708 · -43473.11%
EPS: $-0.01 · 0.00%
Op Income: $-764,560
FCF YoY: -252.14%

Performance & Tape

52W High: $0.00
52W Low: $0.00
50D MA: $0.00
200D MA: $0.00
Beta: 8.55
Avg Volume: 4.75M

Get TickerSpark's AI analysis on CBIA

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · CBIA